Meanwhile, EcN (BAD−904) administration effectively inhibited tumorigenesis in CAC mouse model, characterized by reduced decrease in body weight, fewer tumor numbers, smaller tumor volumes, and significantly decreased Ki−67 expression (Figure S12A−E). Here, MKI67 is linked to neoplasm.